Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	651
Overall Study	STARTED	Placebo Matching RotaTeq™	661
Overall Study	Vaccinated at Visit 1	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	650
Overall Study	Vaccinated at Visit 1	Placebo Matching RotaTeq™	660
Overall Study	Vaccinated at Visit 2	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	618
Overall Study	Vaccinated at Visit 2	Placebo Matching RotaTeq™	627
Overall Study	Vaccinated at Visit 3	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	593
Overall Study	Vaccinated at Visit 3	Placebo Matching RotaTeq™	608
Overall Study	COMPLETED	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	593
Overall Study	COMPLETED	Placebo Matching RotaTeq™	607
Overall Study	NOT COMPLETED	RotaTeq™ at Expiry Potency (≈1.1 x 10^7 IU/Dose)	58
Overall Study	NOT COMPLETED	Placebo Matching RotaTeq™	54

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00092443/flow